Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age–period–cohort analysis

doi:10.1038/bjc.2011.301

Br J Cancer. 2011 August 23; 105(5): 723–730.

Published online 2011 August 9. doi: 10.1038/bjc.2011.301

PMCID: PMC3188937

Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976–2005: an age–period–cohort analysis

P K Dhillon,^1,²^* B B Yeole,¹ R Dikshit,³ A P Kurkure,¹ and F Bray⁴

¹Mumbai Cancer Registry, Indian Cancer Society, Mumbai, India

²South Asia Network for Chronic Disease, Public Health Foundation of India, C-1/52 Safdarjung Development Area, First Floor, New Delhi, 110016, India

³Department of Epidemiology, Tata Memorial Hospital, Mumbai, India

⁴Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

^*E-mail: preet.kaur.dhillon/at/gmail.com

Deceased.

Received April 6, 2011; Revised June 27, 2011; Accepted June 30, 2011.

Abstract

Background:

Demographic, socioeconomic and cultural changes in India have increased longevity, delayed childbearing, decreased parity and resulted in a more westernised lifestyle, contributing to the increasing burden of cancer, especially among women.

Methods:

We evaluated secular changes in the incidence of breast, cervical and ovarian cancer in Mumbai women aged 30–64 between 1976 and 2005. Age-standardised incidence rates were calculated and presented by site and calendar period. An age–period–cohort (APC) analysis quantified recent time trends and the significance of birth cohort and calendar period effects. The estimated annual percent change (EAPC) was obtained from the drift parameter, expressing the linear time trend common to both calendar period and birth cohort.

Results:

Over the 30-year study period, the age-standardised rates significantly increased for breast cancer (EAPC: 1.1% (95% confidence interval (CI): 1.0, 1.3)), significantly decreased for cervical cancer (EAPC: −1.8% (95% CI: −2.0, −1.6)) and there was no statistically significant change for ovarian cancer (EAPC: 0.3% (95% CI: −0.1, 0.6)). For breast and cervical cancer, the best-fitting model was the APC model.

Conclusions:

The rates of breast, cervical and ovarian cancer remain low in comparison with western countries, and the divergent trends of breast (increasing) and cervical cancer (decreasing) in Mumbai were similar to those observed in several other Asian countries. The changing risk profile in successive generations – improved education, higher socioeconomic status, later age at marriage and at first child, and lower parity – may in combination partially explain the diverging generational changes in breast and cervical cancer in Mumbai in the last decades.

Keywords: neoplasm, breast, ovary, cervix, time trends, India

The increasing incidence of cancer in India has mirrored trends in developed countries, although the rates for major sites, such as female breast cancer have remained comparatively low. Over the last two decades, the urbanisation and increasing modernisation of India has transformed education, lifestyle, health-care access and longevity, and has contributed to an increased risk profile for chronic diseases such as cancer (Reddy, 1993, 2007; Murray and Lopez, 1996; Ghaffar et al, 2004). In the large metropolitan cities of India, such as Mumbai (formerly Bombay), these transitions are apparent in women, for whom the pursuit of higher education, entry into the workforce, delayed childbearing and lower parity are characteristic of those in more recent generations (National Family Health Survey India (NFHS-1) 1992–93: Maharashtra, India, 1995; National Family Health Survey India (NFHS-2): 1998–99 Maharashtra, India, 2000). A higher per capita increase has also paralleled a shift in dietary practices towards a greater consumption of animal products and total fat, (World Bank. World development report, 1993; Shetty, 2002) more sedentary lifestyles and increasing prevalence of overweight and obesity in higher social classes of Indian cities, (Singh et al, 1999; Vaz and Bharathi, 2000; Gupta et al, 2003) estimated at 29.7% in a recent survey of Mumbai women (Shukla et al, 2002).

This study aims to quantify the recent time trends in the most commonly occurring female cancers in Mumbai women, with a view to better understanding the contribution of changing lifestyle. An age–period–cohort (APC) analysis of breast, ovarian and cervical cancer incidence trends was conducted, using the population-based cancer registry data in Mumbai, India over a 30-year period, 1976–2005.

Materials and methods

Incidence

All incident cases of breast, ovarian and cervical cancer (ICD-10 C50, C53 and C56, respectively) diagnosed in 1976–2005 were extracted from the Mumbai Cancer Registry. Registry personnel conducted routine visits to 140 collaborating hospitals over a 603 square kilometre area of over 12 million residents to review pathology logs on new cancer diagnoses. Medical charts and pathology reports were reviewed for clinical information including date and method of diagnosis, histological grade and subtype, and stage of disease as well as demographic information such as age, gender, ethnicity and marital status. The Mumbai Registry data set has consistently met IARC's quality standards with respect to inclusion in consecutive volumes of their Cancer Incidence of Five Continents series (Parkin et al, 2005; Curado et al, 2007).

The study population included women aged 30–64 years of age who were residents of Mumbai between 1976 and 2005. Annual population estimates were interpolated from decennial Census of India data (Census of India: Census population tables Maharashtra part IIC 1981; Census of India: Census population tables. Maharashtra part IIA 1991; Census of India: Series 28, Maharashtra provisional population 2001). Subjects were categorised into seven 5-year age groups (30–34, 35–39…60–64) and six 5-year calendar periods (1976–1980, 1981–1985…2001–2005) based on their respective age and year of diagnosis. Twelve 10-year synthetic birth cohorts (1911–1920, 1921–1930…1966–1975) were obtained by subtracting the midpoint of 5-year age band from the central year of the 5-year period of diagnosis.

Statistical analyses

Age-standardised incidence rates truncated for the age group 30–64 were calculated using the Segi/Doll world standard (Segi and Kurihara, 1960; Doll et al, 1966) by cancer site and calendar period. Graphical descriptions of the age-specific incidence rates according to cohort and period are shown for each age group on a semi-log scale. Relatively parallel lines on the period (cohort) scale of these graphs are indicative of the importance of period (cohort) effects. Period effects denote systematic changes that affect rates in all study age groups at a given point in time, often representing artefacts such as changes in completeness of registration, diagnostic practices or disease classification. They can, however, occur through the introduction of specific environmental factors to which all population members are exposed irrespective of age, or as a result of interventions such as screening that affect all age groups at certain point in calendar time. Cohort effects tend to reflect changes in exposure to the risk factors that are in operation in successive generations; these may relate to birth itself or approximate factors related to birth by exerting influences that are shared in the same group as they age together.

A more formal assessment of the contribution of age, period and cohort effects involved the fitting of APC models to the trends (Clayton and Schifflers, 1987a, 1987b). Overall goodness-of-fit tests as well as statistical tests for the contribution of the overall slope (net drift) and the effects of period and cohort curvature, were obtained using the analysis of deviance of nested models, as suggested by Clayton and Schifflers (1987b). In this framework, the importance of non-linear period and cohort effects is statistically tested on comparison with the simple trend model (age-drift model) as well as the two-factor (age–period and age–cohort) models. The final model was selected on the grounds of parsimony, using the log-likelihood ratio test to evaluate nested models on the basis of the addition of cohort and period terms. We used results from the age-drift model to summarise the magnitude and direction of temporal trends over the period 1991–2005. The net drift parameter is a one-degree-of-freedom linear term for time that represents the estimated annual percent change (EAPC) in the rates over the passage of time that is common to calendar period and birth cohort (Clayton and Schifflers, 1987a). The EAPC is the average change in the trend over the designated time of study and is linear on a log scale and thus comparable irrespective of the magnitude of the rates at baseline.

Finally, the APC model analysis included a presentation of the model effects on assuming a period slope of zero, that is, allocating the drift to birth cohort (Holford, 1991). This is an arbitrary assignment to obtain a unique solution, and must be interpreted with considerable caution. Nevertheless, it is not without a certain rationale given an a priori hypothesis that the increasing trends in breast and ovarian cancer, for example, are allied to generational influences; a changing prevalence and distribution of known and unknown lifestyle and environmental factors in the female population of Mumbai, should, given a sufficient time lag, result in changing cancer rates observed in successive birth cohorts. Stata (StataCorp., 2007) and R (R Development Core Team, 2008) were used for data management and analysis.

Results

Breast and cervical cancer were the most frequent cancers occurring in Mumbai women and together with ovarian cancer, accounted for more than half of all female cancers in the study period (Table 1). The rates of breast cancer among women aged 30–64 have risen gradually over the 30-year study period, with the mean increase estimated at 1.1% per year, and representing 32% of the female cancer burden in 2001–2005. In contrast, cervical cancer rates among women in the same age range decreased by 1.8% per year on average but still represents 16% of the total female cancer burden in the latest 5-year period. The age-standardised incidence of ovarian cancer among 30- to 64-year old women were reasonably stable overall, with the proportion of total female cancer incidence remaining at 7% over time.

Table 1

Number of cases and age-adjusted incidence rates for females in Mumbai, India 1976–1980 and 2001–2005 (average annual population at risk, 1.01 and 2.12 million, respectively)

Breast cancer

The age-standardised female breast cancer rates for women in Mumbai were consistently lower than women of other medium-resource countries (Figure 1A), despite the significant average increases over the 30-year period of 1.1% per annum (Table 1). The changes in rates were smaller within the latest 15-year period. The magnitude and change of incidence rates over time were similar to women in Shanghai, China and ca 2000, rates in Mumbai were one-third of those seen in white women diagnosed with breast cancer in the United States (Figure 1A). The respective graphs of rates by calendar period and birth cohort indicate lower age-specific rates for women diagnosed in earlier time periods and for those born in earlier cohorts (Figure 2A). The close-to parallel lines exhibited between successive birth cohorts and periods of diagnosis convey little with regards the relative importance of cohort and period curvature, although there is a point of deflection downwards across all ages in the period 1996–2000 (except 45–49 year olds, where there was a slight increase) followed by an increase restricted to older women in the last period. The APC model analyses in Tables 2 indicates that non-linear period and cohort effects were both significant, yielding the full APC model as the best fitting for breast cancer trends in Mumbai women. In Figure 3A, the drift is added to the non-linear birth cohort effects, and therefore conveys the rather linear increases in successive generations as well as the period curvature resulting from small declines in the last decade, especially in younger women (age <50 years).

Figure 1

Comparison of time trends of truncated (30–64 years) age-standardised (world) rates of (A) female breast cancer; (B) cervical cancer; (C) ovarian cancer in Mumbai females 1976–2005, vs selected populations worldwide 1973–2002, (more ...)

Figure 2

Observed rates of (A) female breast cancer; (B) cervical cancer; (C) ovarian cancer in Mumbai females aged 30–64 and diagnosed 1976–2005. Rates are plotted vs calendar period and birth cohort for each age at diagnosis group.

Table 2

Analysis of deviance of age–period–cohort models: overall goodness-of-fit and significance of model effects by cancer, trends in incidence in Mumbai 1976–2005

Figure 3

Graphical representation of parameters from the full APC models of (A) female breast cancer, (B) cervical cancer and (C) ovarian cancer of Mumbai females aged 30–64 and diagnosed 1976–2005 on specifying a period slope of zero, thereby (more ...)

Cervical cancer

The trend for cervical cancer among Mumbai women was consistent with a general pattern of declines in many populations worldwide (Figure 1B). The age-specific rates decreased for all women aged 30–64 (1.8% decline overall, Table 1) with the downwards trends more striking – a mean decline of 2.8% per annum – in the most recent period 1991–2005 (Table 1) and for women under the age of 50 years (Figure 2B), and the greatest changes observed among younger women (Table 2). The analysis of deviance indicated a significant lack-of-fit of the full APC model and significant non-linear effects for both birth cohort and calendar period. The downward concavity in the period effects as shown in Figure 3 suggests a slight deceleration in the rate of decline over time, and the APC analysis shows it is weaker than the cohort effect (Table 2).

Ovarian cancer

The absolute and relative change in Mumbai's ovarian cancer rates over time was minor compared with other countries overall (Figure 1C). The rates in Mumbai remained intermediate between that of Cali, Colombia and Shanghai, China women throughout the 30-year period, while female rates in Miyagi, Japan overtook Mumbai women by the late 1990s from a baseline rate one-third that of Mumbai 1976–1980. In Mumbai, the rates fluctuated between an increasing trend up to the mid-1990s to slight decreases thereafter (Figure 1C). We also observed fluctuations in the trend by age group (Figure 2C). There was no significant change in rates over time, and the analysis of deviance indicated that the age–period model was the most parsimonious APC model. The significant non-linear period effect (Table 2) may have resulted from a minor decline within the last three calendar periods, 1991–2005 (Figure 2C).

Discussion

This study has shown that the evolution of breast, cervical and ovarian cancer rates over 30 years in Mumbai, India is similar to the population trends in several other Asian and low-to-medium-resource countries. The annual rate of breast cancer significantly increased during the period 1976 and 2005, while cervical cancer rates significantly decreased. For all three sites, secular changes at the population level need to be examined in terms of the possible screening interventions and/or changing diagnostic patterns (as possible period effects) against a changing prevalence and distribution of risk factors, which may show up as changes in rates among successive generations (cohort effects).

Age–period–cohort analyses of secular changes in breast cancer have yielded different temporal patterns for western vs Asian countries (Seow et al, 1996; Leung et al, 2002; Li and Daling, 2007). In the United States and Canada, breast cancer increased in the 1980s and 1990s, and began to plateau in the late 1990s, (Li et al, 2003; Althuis et al, 2005), most likely due to a saturation of mammography screening (Li and Daling, 2007), which suggests stronger period effects. In Asian countries, where rates are lower and trends tend to be still increasing, tumours are predominantly detected by physical examination (with the exception of Japan (Shapiro et al, 1998)). Studies in the region have tended to attribute the increase to cohort effects (Seow et al, 1996; Leung et al, 2002) and a general westernisation effect that may include changes in dietary and fertility patterns alongside an increasingly affluent and sedentary lifestyle (Jin et al, 1999; Yip et al, 2001; Leung et al, 2002).

For ovarian cancer, the trends vary according to geographic region – with decreasing rates in the United States and northern Europe (Kjaerbye-Thygesen et al, 2005; Bray et al 2005c; Morris et al, 2008) but increasing rates in a few southern and eastern European countries and in Asian countries including Japan, China and Hong Kong (Marugame and Hirabayashi, 2007; Song et al, 2008). For cervical cancer and squamous cell carcinoma specifically, the time trends are more consistent worldwide, with systematic decreases since the 1980s or 1990s (Levi et al, 1994; Walker et al, 1998; Liu et al, 2001; Siesling et al, 2008) attributable to effective screening programmes and changing sexual behaviour allied to the acquisition and persistent infection of high-risk HPV types (Minami et al, 1996; Bergstrom et al, 1999; Liu et al, 2001; Taylor et al, 2001; Bray et al, 2005a). The incidence of cervical adenocarcinoma in our population was too low for APC modelling, but we did find a slight increase in the proportion of adenocarcinomas from 4.7% of all cervical cancers in 1976 to 5.4% in 2000 (data not shown), which is also consistent with the increasing trend observed by others in developed countries (Visioli et al, 2004; Wang et al, 2004; Bulk et al, 2005; Bray et al, 2005b).

On the surface, a limitation of this study is the lower proportion of microscopically confirmed cases, as compared with many Western registries. In 1993–1997, the Mumbai cancer registry had histological verification for 84%, 84% and 77% of breast, cervical and ovarian cancer cases, respectively (Yeole, 2001). A relatively low proportion of morphological verification is in part, however, the result of highly qualified medical personnel using radiological and other less costly evidence for determining cancer diagnoses; cases more often present with metastatic disease. Data in this medium-resource setting have, however, been shown to be reasonably reliable and complete (Yeole and Jussawalla, 1988), and the registry data have met the criteria for inclusion in successive volumes of IARC's Cancer Incidence in Five Continents (IARC) publications.

A limitation to using APC modelling is that the models do not account for linear generational changes in the rates and given the complexity of trends, the APC models may therefore be considered a rather blunt instrument for detecting non-linear effects only. However, the models detected significant cohort and period effects for both cervical and breast cancer, where clear trends were observed. For ovarian cancer, where there was no clear overall trend, the APC model still yielded a significant period effect, explaining the consistent decrease observed across all the age groups in the last period (Figure 2C).

The relative straightforwardness of fitting APC models is at odds with the difficulties in providing an informed presentation of the model parameters, given the irresolvable issue of non-identifiability. One further linear constraint must be imposed to ensure a unique solution, but the crux of the problem is that the choice of model constraint and the resulting parameter estimates are completely arbitrary in the absence of compelling external information that one can bring to bear in making the selection. We have assumed generational influences predominate for all three cancers and that they reflect a changing prevalence and distribution of risk factors in the female population of Mumbai. While a non-zero period slope for some of these trends cannot be entirely dismissed – for example, via changing levels of case ascertainment – it is unlikely to explain the long-term increases in the regular trend.

Another limitation of this study is its ecological approach, which prevents causal inferences of associations between observed trends at the population level and risk factors at the individual level. However, these analyses are an effective and resource-efficient method for evaluating temporal trends at the population level and whether observed changes might reflect data artefacts, interventions or a true underlying change in risk, a critical step before more costly analytic studies of putative risk factors in various Indian communities are considered.

Breast cancer

The APC models yielded significant cohort and period effects for breast cancer, suggesting that underlying risk factor patterns as well as changes in awareness, screening and/or diagnostic procedures may explain the significant increasing trends for breast cancer risk in Mumbai women over the 30-year study period. Increasing rates may be attributed to later age at first birth and lower total parity of more recent generations (National Family Health Survey India (NFHS-1) 1992–93: Maharastra, India, 1995; National Family Health Survey India (NFHS-2): 1998–99 Maharastra, India, 2000). In a case series of 11780 tumours (Shet et al, 2009) from the largest tertiary care referral centre for the Mumbai Cancer Registry, the investigators reported a redistribution of hormone receptor expression over an 8-year period – ER+ (7.5–10.6%) and ER+/PR+ status (25 to 41.8%) increased between 1999 and 2006 while PR+ decreased (21–3.4%). This lends support to the hypothesis that changing reproductive factors may have a role in the observed trends. Although there is no population-based organised breast cancer screening programme for women in the region, the increasing use of mammography and a heightened awareness among physicians and patients led to improvements in the clinical extent of disease at diagnosis over time. Among newly diagnosed cases, a third presented with localised disease in 1976 (33.8%) while nearly half had localised disease in 2000 (49.6%), and the proportion with metastatic disease decreased from 51.6 to 37.6% over the same time period (data not shown).

Cervical cancer

The significant decline in cervical cancer, once the most common cancer of Mumbai women, is likely due to changes in marriage and family planning, supported by underlying improvements in education and socioeconomic status. Generational changes in age at marriage and first pregnancy (National Family Health Survey India (NFHS-1) 1992–93: Maharashtra, India, 1995; National Family Health Survey India (NFHS-2): 1998–99 Maharashtra, India, 2000) have resulted in a later age at first intercourse, the primary risk factor for cervical cancer in Indian women (Prabhakar and Menon, 1995; Juneja et al, 2003). Higher education and socioeconomic status are associated with lower cervical cancer rates in India (Capalash and Sobti, 1999) through older age at marriage, fewer partners and pregnancies over time and through higher uptake of screening services (Shanta et al, 2000) and targeted cervical cancer screening and treatment interventions in rural areas have been shown to have a greater impact among women who are married, more highly educated and nulliparous (Nene et al, 2007). More rapid changes observed in younger birth cohorts may in part, explain the steeper declines observed in women under the age of 40 when comparing age-specific rates over time (Figure 2B).

Ovarian cancer

Although ovarian cancer rates in Mumbai were half those in the United States in 1976 (Figure 1C), it ranked as the third most common neoplasm in Mumbai women by the year 2000 (Kavarana et al, 2000) and accounted for about 7% of the cancer incidence in the population. The best-fitting APC model for ovarian cancer had significant period effects with no significant change in rates over time. In Mumbai, diagnostic testing tends to be centralised in a few large hospitals (Kavarana et al, 2000), so the introduction of new equipment may have a more immediate impact on incidence rates, which may explain the observed increase in rates from the mid-1980s to mid-1990s across all age groups (Figure 2C). However, the subsequent decline in rates, across most age groups suggests that this factor did not have a large role; moreover, our data did not yield earlier stages at diagnosis over time. Unlike breast cancer, the clinical extent of disease remained stable (49.5% with localised disease in 1976 and 49.7% in 2000; data not shown) and the proportion of women with metastatic ovarian cancer at diagnosis did not change over the 30-year period (37.8% in 1976 and 38.5% in 2000; data not shown). And the 5-year survival of ovarian cancer patients in Mumbai remains low at 25.4% (Yeole et al, 2004), considerably lower than the proportions observed in the United States, Europe and other Asian countries. It is unclear that hormonal risk factors, such as age at menarche or menopause changed over time and the prevalence of other risk factors such as cigarette smoking and exogenous hormone use have remained relatively low in Mumbai women – only 1.1% of women 35 years and older reported smoking in a 1991–1992 baseline survey of a tobacco-associated cohort (Pednekar et al, 2006) while 2.5% were current users of oral contraceptives in 1999 (National Family Health Survey India (NFHS-2): 1998–99 Maharashtra, India, 2000).

APC models

The APC models yielded significant non-linear cohort effects for underlying changes in breast and cervical cancer risk, which is consistent with the adoption of modern reproductive practices. Lifestyle patterns of Mumbai females changed considerably during the study period; women in Mumbai attained higher levels of education, postponed marriage, had their first child at an older age and had fewer pregnancies over time (National Family Health Survey India (NFHS-1) 1992–93: Maharashtra, India, 1995; National Family Health Survey India (NFHS-2): 1998–99 Maharashtra, India, 2000). Furthermore, India's economic developments have led to changes in diet and anthropometrics (World Bank. World development report, 1993), particularly for the higher socioeconomic classes; higher-income Indian women had 32% of their total energy from fat (Shetty, 2002) and college-educated Mumbai females had a 90% increased risk for overweight compared with illiterate women (95% CI: 1.64, 2.20) (Shukla et al, 2002). Both dietary fat and high body mass index are important risk factors for pre- and postmenopausal breast cancer (Wu et al, 1999; Key et al, 2003).

A graphical display of the APC parameters was included in this study, although a meaningful ‘solution' – one that numerically allocates the drift to period and cohort on the basis of a priori epidemiological or biological knowledge – was beyond our present understanding of the trends, and instead we assumed a period slope of zero, allowing for the drift to be included in birth cohort. This method still allows non-linear effects for period to be visible (Holford, 1991). There may be some latency effects whereby cancers will become clinically manifest as time accrues – the effects of changing lifestyle and reproductive patterns including later age at first birth, fewer children and a higher prevalence of obesity in Mumbai women in any case may take one or more decades before they manifest themselves clinically, especially in the older age groups. And yet, the APC models detected significant effects, suggesting the method is adequate for detecting important factors in the complex trends of these three diseases.

Conclusions

Overall, trends in breast cancer and cervical cancer incidence rates in Mumbai, India mirrored those observed in Western countries over the same 30-year time period. The changing risk profile among younger generations allied to a westernisation of lifestyle – improved education, higher socioeconomic status, later age at marriage and at first child, and lower parity – explain part of the generational changes that yielded significant changes for both cervical and breast cancer rates over time.

Acknowledgments

We dedicate this paper to the memory of our co-author, colleague and friend, Professor BB Yeole, who passed away in January 2011. Professor Yeole was the longstanding Director of the Mumbai Cancer Registry and one of the chief architects of cancer registration in India. Dr Dhillon was supported by an International Agency for Research on Cancer Research Training Fellowship and a Cancer Epidemiology Training Grant NCI T32 CA009001. The Mumbai Cancer registry has been partly funded by the National Cancer Registry Program of the Indian Council of Medical Research since 1982.

Footnotes

This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.

References

Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–412. [PubMed]
Bergstrom R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81:159–166. [PMC free article] [PubMed]
Bray F, Carstensen B, Møller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 2005a;14:2191–2199. [PubMed]
Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, Hakama M, Parkin DM. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev. 2005b;14:677–686. [PubMed]
Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer. 2005c;113:977–990. [PubMed]
Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer. 2005;113:1005–1009. [PubMed]
Capalash N, Sobti RC. Epidemiology of cervical cancer--a case control study on North Indian population. Indian J Cancer. 1999;36:179–185. [PubMed]
Census of India: Census population tables Maharashtra part IIC 1981. Directorate of census application, Mumbai.
Census of India: Census population tables. Maharashtra part IIA 1991. Directorate of census application, Mumbai.
Census of India: Series 28, Maharashtra provisional population 2001. Directorate of census application, Mumbai.
Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med. 1987a;6:449–467. [PubMed]
Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period-cohort models. Stat Med. 1987b;6:469–481. [PubMed]
Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. 2007. Cancer Incidence in Five ContinentsVol. IXIARC Scientific Publications No.160. IARC: Lyon.
Doll R, Payne P, Waterhouse J. Cancer Incidence in Five Continents: A Technical Report. Springer: New York; 1966.
Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ. 2004;328:807–810. [PMC free article] [PubMed]
Gupta R, Gupta VP, Sarna M, Prakash H, Rastogi S, Gupta KD. Serial epidemiological surveys in an urban Indian population demonstrate increasing coronary risk factors among the lower socioeconomic strata. J Assoc Physicians India. 2003;51:470–477. [PubMed]
Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health. 1991;12:425–457. [PubMed]
Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Jr, Gao YT. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer. 1999;83:435–440. [PubMed]
Juneja A, Sehgal A, Mitra AB, Pandey A. A survey on risk factors associated with cervical cancer. Indian J Cancer. 2003;40:15–22. [PubMed]
Kavarana NM, Kamat MR, Kurkure AP, Yeole BB, Sunny L. 2000. Cancer Morbidity and Mortality in Greater MumbaiMumbai Cancer Registry, National Cancer Registry Project, Indian Council of Medical Research.
Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C., Endogenous Hormones Breast Cancer Collaborative Group Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95:1218–1226. [PubMed]
Kjaerbye-Thygesen A, Huusom LD, Frederiksen K, Kjaer SK. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries. Acta Obstet Gynecol Scand. 2005;84:1006–1012. [PubMed]
Leung GM, Thach TQ, Lam TH, Hedley AJ, Foo W, Fielding R, Yip PS, Lau EM, Wong CM. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer. 2002;87:982–988. [PMC free article] [PubMed]
Levi F, La Vecchia C, Randimbison L, Te VC. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991. Ann Oncol. 1994;5:747–752. [PubMed]
Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289:1421–1424. [PubMed]
Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev. 2007;16:2773–2780. [PubMed]
Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer. 2001;11:24–31. [PubMed]
Marugame T, Hirabayashi Y. 2007. Comparison of time trends in ovary cancer incidence (1973–1997) in East Asia, Europe, and the USA, from Cancer Incidence in Five ContinentsVols. IV, VIIIJpn J Clin Oncol 37802–803.803. [PubMed]
Minami Y, Takano A, Okuno Y, Fukao A, Kurihara M, Hisamichi S. Trends in the incidence of female breast and cervical cancers in Miyagi Prefecture, Japan, 1959-1987. Jpn J Cancer Res. 1996;87:10–17. [PubMed]
Morris CR, Rodriguez AO, Epstein J, Cress RD. Declining trends of epithelial ovarian cancer in California. Gynecol Oncol. 2008;108:207–213. [PubMed]
Murray CJL, Lopez AD. Global Health Statistics. Global Burden of Disease and Injury Series. Harvard School of Public Health: Boston, MA; 1996.
National Family Health Survey India (NFHS-1) (1992–93): Maharashtra, India 1995. International Institute for Population Sciences (IIPS)
National Family Health Survey India (NFHS-2): (1998–99) Maharashtra, India 2000. International Institute for Population Sciences (IIPS)
Nene B, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S, Muwonge R, Malvi S, Dinshaw K, Sankaranarayanan R. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ. 2007;85:264–272. [PubMed]
Parkin DM, Whelan SL, Ferlay J, Storm H., International Agency for Research on Cancer 2005. International Association of Cancer Registries. Cancer Incidence in Five Continents.Vols. I to VIIIIARC Press: Lyon, France.
Pednekar MS, Gupta PC, Shukla HC, Hebert JR. Association between tobacco use and body mass index in urban Indian population: implications for public health in India. BMC Public Health. 2006;6:70. [PMC free article] [PubMed]
Prabhakar AK, Menon GR. Age at marriage and cervical cancer incidence. Indian J Cancer. 1995;32:63–68. [PubMed]
R Development Core Team 2008. R: A Language and Environment for Statistical Computing. R Foundation for Statistical ComputingVienna, Austria. ISBN 3-900051-07-0, URL: http://www.R-project.org.
Reddy KS. Cardiovascular diseases in India. World Health Stat Q. 1993;46:101–107. [PubMed]
Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol. 2007;50:1370–1372. [PubMed]
Segi M, Kurihara M. 1960. Cancer Mortality for Selected Sites in 24 Countries (1950–1957)2nd edn.Tohoku University of Medicine: Sendai.
Seow A, Duffy SW, McGee MA, Lee J, Lee HP. Breast cancer in Singapore: trends in incidence 1968–1992. Int J Epidemiol. 1996;25:40–45. [PubMed]
Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc. 2000;98:49–52. [PubMed]
Shapiro S, Coleman EA, Broeders M, Codd M, de Koning H, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard-Barbash R. Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol. 1998;27:735–742. [PubMed]
Shetty PS. Nutrition transition in India. Public Health Nutr. 2002;5:175–182. [PubMed]
Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, Badwe R, Chinoy RF. Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is. Indian J Pathol Microbiol. 2009;52:171–174. [PubMed]
Shukla HC, Gupta PC, Mehta HC, Hebert JR. Descriptive epidemiology of body mass index of an urban adult population in western India. J Epidemiol Community Health. 2002;56:876–880. [PMC free article] [PubMed]
Siesling S, van der Aa MA, Coebergh JW, Pukkala E. Time-space trends in cancer incidence in the Netherlands in 1989-2003. Int J Cancer. 2008;122:2106–2114. [PubMed]
Singh RB, Beegom R, Mehta AS, Niaz MA, De AK, Mitra RK, Haque M, Verma SP, Dube GK, Siddiqui HM, Wander GS, Janus ED, Postiglione A, Haque MS. Social class, coronary risk factors and undernutrition, a double burden of diseases, in women during transition, in five Indian cities. Int J Cardiol. 1999;69:139–147. [PubMed]
Song F, He M, Li H, Qian B, Wei Q, Zhang W, Chen K, Hao X. A cancer incidence survey in Tianjin: the third largest city in China-between 1981 and 2000. Cancer Causes Control. 2008;19:443–450. [PubMed]
StataCorp Stata Statistical Software: Release 10. StataCorp LP: College Station, TX; 2007.
Taylor RJ, Morrell SL, Mamoon HA, Wain GV. Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Community Health. 2001;55:782–788. [PMC free article] [PubMed]
Vaz M, Bharathi AV. Practices and perceptions of physical activity in urban, employed, middle-class Indians. Indian Heart J. 2000;52:301–306. [PubMed]
Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000. Cancer Detect Prev. 2004;28:461–464. [PubMed]
Walker JJ, Brewster D, Gould A, Raab GM. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994) Public Health. 1998;112:373–378. [PubMed]
Wang SS, Sherman ME, Hildesheim A, Lacey JV, Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100:1035–1044. [PubMed]
World Bank. Invest in health World Development Report 1993. Oxford University Press: Oxford; 1993. pp. 195–324.
Wu AH, Pike MC, Stram DO. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl Cancer Inst. 1999;91:529–534. [PubMed]
Yeole BB, Jussawalla DJ. An assessment of reliability and completeness of Bombay Cancer Registry data (1963 – 1985) Indian J Cancer. 1988;25:177–190. [PubMed]
Yeole BB, Kumar AV, Kurkure A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev. 2004;5:308–315. [PubMed]
Yeole BB. An Assessment of Improvement in Reliability and Completeness of Mumbai Cancer Registry Data from 1964-1997. Asian Pac J Cancer Prev. 2001;2:225–232. [PubMed]
Yip PS, Lee J, Chan B, Au J. A study of demographic changes under sustained below-replacement fertility in Hong Kong SAR. Soc Sci Med. 2001;53:1003–1009. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of
Cancer Research UK